A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

NCT07303660 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: ZE50-0134
DRUG: Azacitidine Days 1-7
DRUG: ZE 50-0134

Sponsor

Lomond Therapeutics Holdings, Inc.